MyFinsight
Home
Blog
About
Maturities of marketable
securities
$40,000K
Proceeds from issuances
of common stock...
$2,102K
Net cash provided by
(used in) investing...
$17,854K
Net cash provided by
financing activities
$2,102K
Canceled cashflow
$22,146K
Net cash increase
(decrease) for the period
-$11,120K
Canceled cashflow
$19,956K
Stock-based compensation
$10,232K
Accounts payable,
accrued expenses and...
$5,318K
Depreciation
$138K
Right-of-use assets and lease
liabilities, net
$17K
Purchases of marketable
securities
$22,080K
Purchases of property and
equipment
$66K
Net cash used in
operating activities
-$31,076K
Canceled cashflow
$15,705K
Net loss
-$45,558K
Prepaid expenses and
other assets
$1,018K
Accretion on marketable
securities, net
-$205K
Back
Back
Cash Flow
Tyra Biosciences, Inc. (TYRA)
Tyra Biosciences, Inc. (TYRA)
source: myfinsight.com